Synthesis and Biological Activities of Indolactone-V, the Lactone Analogue of the Tumor Promoter (–)-Indolactam-V

Bioscience, Biotechnology and Biochemistry

Volumn 61, Issue 8, 1997, Pages 1415-1417

  Nakagawa, Yu ^a   Irie, Kazuhiro ^a   Nakamura, Yoshimasa ^a   Ohigashi, Hajime ^a   Hayashi, Hideo ^b  

^a KYOTO UNIVERSITY   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

( ) indolactam V; Conformation; Indolactone V; Protein kinase C; Teleocidin; Tumor promoter

Indexed keywords

CARCINOGEN; INDOLACTAM V; INDOLACTONE V; INDOLE DERIVATIVE; LACTAM; LACTONE; PROTEIN KINASE C;

ARTICLE; AUDIOVISUAL EQUIPMENT; CHEMISTRY; CONFORMATION; DRUG EFFECT; EPSTEIN BARR VIRUS; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

CARCINOGENS; HERPESVIRUS 4, HUMAN; INDOLES; LACTAMS; LACTONES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, STRUCTURAL; MOLECULAR CONFORMATION; PROTEIN KINASE C;

EID: 0031201509     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.61.1415     Document Type: Article

References (17)

1. Y. Endo, K. Shudo, and T. Okamoto, Chem. Pharm. Bull., 30, 3457-3460 (1982).
2. K. Irie, M. Hirota, N. Hagiwara, K. Koshimizu, H. Hayashi, S. Marao, H. Tokuda, and Y. Ito, Agric. Biol. Chem., 48, 1269-1274 (1984).
3. H. Fujiki and T. Sugimura, Adv. Cancer. Res., 49,223-264 (1987).
4. Y. Nishizuka, Nature, 308, 693-698 (1984).
5. K. Irie, Nippon Nogeikagaku Kaishi (in Japanese), 68, 1289-1296 (1994).
6. Y. Endo, K. Shudo, A. Itai, M. Hasegawa, and S. Sakai, Tetrahedron, 42, 5905-5924 (1986).
7. Y. Endo, M. Ohno, M. Hirano, A. Itai, and K. Shudo, J. Am. Chem. Soc., 118, 1841-1855 (1996).
8. K. Irie, T. Isaka, Y. Iwata, Y. Yanai, Y. Nakamura, F. Koizumi, H. Ohigashi, P. A. Wender, Y. Satomi, and H. Nishino, J. Am. Chem. Soc., 118, 10733-10743 (1996).
9. S. Nakatsuka, T. Masuda, K. Sakai, and T. Goto, Tetrahedron Lett., 27, 5735-5738 (1986);
10. T. P. Kogan, T. C. Somers, and M. C. Venuti, Tetrahedron, 46, 6623-6632 (1990).
11. S. Kajiyama, K. Irie, T. Kido, K. Koshimizu, H. Hayashi, and M. Arai, Tetrahedron, 47, 5453-5462 (1991).
12. K. Irie, M. Iguchi, T. Oda, Y. Suzuki, H. Ohigashi, K. Koshimizu, H. Hayashi, M. Arai, and H. Nishino, Tetrahedron, 51, 6255-6266 (1995).
13. Indolactone-V (2): [a]D +31.3° (c = 0.34, MeOH, 23°C); UV 2max (MeOH) nm (e): 292 (6,500), 224 (25,500); NMR <5C (CDC13, 500 MHz, 0.05 m): 19.36 (C-17), 19.60 (C-16), 25.21 (C-15), 27.80 (C-8), 35.57 (C-18), 62.64 (C-14), 74.48 (C-12), 76.39 (C-9), 109.12 (C-3), 109.82 (C-7), 121.80 (C-5), 122.71 (C-6), 124.35 (C-2), 127.90 (C-3a), 139.06 (C-7a), 145.53 (C-4), 169.13 (C-ll); HR-EIMS m/z: 302.1628 (M +, ealcd. for C17H22N203, 302.1630).
14. P. A. Wender, K. Irie, and B. L. Miller, Proc. Natl. Acad. Sci. U.S.A., 92, 239-243 (1995).
15. K. Irie, Y. Yanai, H. Ohigashi, P. A. Wender, and B. L. Miller, Bioorg. Med. Chem. Lett., 6, 353-356 (1996).
16. N. A. Sharkey and P. M. Blumberg, Cancer Res., 45,19-24 (1985).
17. Y. Ito, S. Yanase, J. Fujita, T. Harayama, M. Takashima, and H. Imanaka, Cancer Lett., 13, 29-37 (1981).